Ralmitaront (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name; developmental code names RG-7906 and RO-6889450) is an investigational antipsychotic drug which is undergoing a clinical trial for the treatment of negative symptoms in schizophrenia and schizoaffective disorder.[1][2][3] Another clinical trial targeting acute psychotic symptoms of schizophrenia has been terminated due to lack of efficacy.[4] It is a partial agonist of the TAAR1.[5] The medication is being developed by the pharmaceutical company Hoffmann-La Roche.[1] Ralmitaront had completed phase 1 clinical trials.[1][6]
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
Lokasi Pengunjung: 3.141.42.253